Tangent Medical Technologies (Ann Arbor, MI) a development-stage medical device company focused on peripheral intravenous delivery systems, closed a $4.5M Series A financing. Participants include Arboretum Ventures, Flagship Ventures and Osage Ventures.

Intervention Insights (Grand Rapids, MI) a commercial-stage personalized medicine company focused on molecularly targeted oncology therapies, closed a $7.2M Series B financing. Participants include Beringea, Chrysalis Ventures, Hopen Life Science Ventures and Michigan Accelerator Fund.
Thanx for your patience as we catch-up.

Molecular Imaging Research (Ann Arbor, MI) a commercial-stage specialty contract research organization providing small animal in vivo multi-modality imaging services, closed a $7M Series A financing. Participants include Baird Venture Partners and Arcus Ventures.

Accuri Cytometers (Ann Arbor, MI) a commercial-stage device company focused on flow cytometery solutions for the R&D market, closed a $6M Series E financing. Participants include Arboretum Ventures, Baird Venture Partners, Fidelity Biosciences, Flagship Ventures and InvestMichigan.

Swift Biosciences (Ann Arbor, MI) a development-stage company focused on molecular biology reagents for R&D and diagnostics, closed a $3M Series A financing. Participants include DFJ Mercury.

Delphinus Medical Technologies (Detroit, MI) a development-stage medical device company focused on tomographic ultrasound imaging for breast cancer, closed an $8M Series A financing. Participants include Arboretum Ventures, Beringea and North Coast Technology Investors.

Advanced Cardiac Therapeutics (Laguna Beach, CA) a development-stage electrophysiology and radiometry medical device company focused on energy delivery via catheters for cardiac ablation, closed a $5M Series b financing. Participants include NBGI Ventures.

HistoSonics (Ann Arbor, MI) a development stage device company focused on non-invasive image-guided tissue ablation for benign prostatic hyperplasia, closed an $11M Series A financing. Participants include Venture Investors, Fletcher Spaght Ventures, Hatteras Venture Partners, Early Stage Partners and TGap Ventures.

Accuri Cytometers (Ann Arbor, MI) a commercial-stage device company focused on cell analysis flow cytometry, closed a $4M Series D financing. Participants include InvestMichigan-Credit Suisse, Fidelity Biosciences, Flagship Ventures, Baird Venture Partners and Arboretum Ventures.

GloStream (Bloomfield Hills, MI) a commercial-stgae healthcare IT company focused on electronic medical records and practice management platforms, closed on a $7.5M Series B financing. Participants include Beringea.

Metabolic Solutions Development (Kalamazoo, MI) a clinical-stage biopharmaceutical company focused on Type II diabetes, closed a $9.5M Series B financing. Participants include Southwest Michigan First Life Science Fund and Hopen Therapeutics.

Lycera Corp (Ann Arbor, MA) a preclinical-stage biopharma company focused on small molecule immunomodulators for the treatment of rheumatoid arthritis, lupus erythematosis and inflammatory bowel disease, closed a $36M Series A financing. Participants include InterWest Partners, ARCH Venture Partners, Clarus Ventures and EDF Ventures.

NanoBio (Ann Arbor, MI) a clinical-stage company focused on topical antiinfectives and mucosal vaccines for the treatment and prevention of herpes labialis, onychomycosis, acne and cystic fibrosis closed a $12M Series B financing. Participants include Perseus.